PHIO PHARMACEUTICALS CORP's ticker is PHIO and the CUSIP is 71880W303. A total of 15 filers reported holding PHIO PHARMACEUTICALS CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $8,521 | +326.0% | 23,029 | +757.7% | 0.00% | – |
| Q1 2022 | $2,000 | -71.4% | 2,685 | -61.6% | 0.00% | – |
| Q4 2021 | $7,000 | -46.2% | 7,000 | +12.2% | 0.00% | – |
| Q3 2021 | $13,000 | +333.3% | 6,241 | +353.2% | 0.00% | – |
| Q2 2021 | $3,000 | -80.0% | 1,377 | -75.5% | 0.00% | – |
| Q4 2020 | $15,000 | +1400.0% | 5,623 | +893.5% | 0.00% | – |
| Q3 2020 | $1,000 | -95.8% | 566 | -94.9% | 0.00% | – |
| Q2 2020 | $24,000 | +2300.0% | 11,159 | +1882.1% | 0.00% | – |
| Q1 2020 | $1,000 | – | 563 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtu Financial LLC | 35,929 | $77,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 21,278 | $46,000 | 0.01% |
| UBS Group AG | 566 | $1,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 33 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| HSBC HOLDINGS PLC | 11,337 | $24,000 | 0.00% |
| BlackRock Inc. | 19 | $0 | 0.00% |
| Citadel Advisors | 12,178 | $26,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 581 | $1,000 | 0.00% |